Cleo Diagnostics Ltd (COV) — Working Capital to Net Assets Ratio
Cleo Diagnostics Ltd (COV) has a Working Capital to Net Assets ratio of 95.9% as of December 2025. Working capital of AU$8.46 Million (current assets of AU$9.60 Million minus current liabilities of AU$1.14 Million) is measured against net assets of AU$8.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See COV net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cleo Diagnostics Ltd Working Capital to Net Assets (2022–2025)
This chart shows how Cleo Diagnostics Ltd's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 95.9%, reflecting working capital of AU$8.46 Million against net assets of AU$8.83 Million AUD. Check COV tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Cleo Diagnostics Ltd (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cleo Diagnostics Ltd from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Cleo Diagnostics Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (AUD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 93.3% | AU$5.44 Million | AU$5.83 Million | AU$6.55 Million | AU$1.10 Million | ▼ -2.0 pp |
| 2024 | 95.3% | AU$8.95 Million | AU$9.39 Million | AU$9.44 Million | AU$486.22K | ▼ -57.3 pp |
| 2023 | 152.6% | AU$-1.44 Million | AU$-943.41K | AU$580.21K | AU$2.02 Million | ▼ -420.4 pp |
| 2022 | 573.0% | AU$-242.28K | AU$-42.28K | AU$43.61K | AU$285.89K | — |